Stock Taper
SCREENER COMPARE ANY 2 STOCKS
BDTX
BLACK DIAMOND THERAPEUTICS, INC.
NASDAQ
$2.23
▼ DOWN 1.76% (-0.04)

KEY STATISTICS

Market Cap$127.78 M
52w High$4.94
52w Low$1.60
Dividend Yield—
Frequency—
P/E-3.01
Volume521.91K
Shares Out.57.30M

COMPANY

LEADERSHIP

Mark A. Velleca
CHIEF EXECUTIVE
Mark A. Velleca

COMPENSATION 2026

Salary$667,400
Stock Awards$189,000
Incentive Plan Pay$348,717
All Other Comp.$23,772
Total$2,234,919

ABOUT

SECTOR
Healthcare
WENT PUBLIC
January 31, 2020
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
21

PRICE TARGET

Target High$20.00
Target Low$8.00
Target Median$9.50
Target Consensus$11.83

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.$8.33M
NOV
5
THU

PRICE

$2.23 ▼ DOWN 1.76% (−$0.04)
$2.20$2.24$2.289:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM2.23

About Black Diamond Therapeutics, Inc.

https://www.blackdiamondtherapeutics.com ↗

Black Diamond Therapeutics, Inc. is a Cambridge-based biotech developing targeted cancer medicines, including BDTX-189, BDTX-1535, and BDTX-4933, for genetically defined tumors with strategic partnerships like OpenEye Scientific Software.

INDUSTRY

Biotechnology

A PRODUCT BLACK DIAMOND THERAPEUTICS, INC. IS KNOWN FOR

Silevertinib (BDTX-1535)
Silevertinib (BDTX-1535)

Silevertinib (BDTX-1535) is a brain-penetrant EGFR inhibitor by Black Diamond Therapeutics, in Phase 2 trials for NSCLC and glioblastoma.

COMPETITORS

COMPETITOR
AVBP COMPARE
CGEM COMPARE
NU NUVL COMPARE

Revenue by Products

IconPRODUCTQ1-2025Q4-2025
Reportable Segment$70M $0 ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
60
LISTED HERE
11
RANKED BY POSITION SIZE
VTS.AX
0.00% · 1.6M
IWM
0.00% · 1.2M
FESM
0.02% · 597.2K
BSVO
0.02% · 264.3K
DFSV
0.01% · 210.2K
PRFZ
0.01% · 94.0K
EES
0.03% · 84.6K
AVSC
0.01% · 73.7K
XRS2.F
0.00% · 43.2K
RSSL
0.00% · 22.4K
BIB
0.00% · 2.0K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
64.53%
HOLDERS
145
TOP 12 OF 145 · RANKED BY POSITION SIZE
T. Rowe Price Investment Management, Inc.
10.7M sh · $40.72M
Vestal Point Capital, LP
5.5M sh · $21.03M
Nea Management Company, LLC
4.4M sh · $10.81M
Blackrock Inc.
3.2M sh · $14.99M
Acadian Asset Management LLC
2.3M sh · $5M
Vanguard Group Inc
2.2M sh · $5.32M
Tang Capital Management LLC
2.1M sh · $7.85M
Renaissance Technologies LLC
1.6M sh · $3.5M
Dimensional Fund Advisors LP
1.3M sh · $2.77M
Marshall Wace, Llp
1.3M sh · $4.92M
Blackrock, Inc.
1.1M sh · $2.36M
Connor, Clark & Lunn Investment Management Ltd.
1.1M sh · $2.25M

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book4
Overall Score3

INSIDER TRADES

★
DIRECTOR
Behbahani Ali
Purchase · 40.0K shares
2026-06-26
★
DIRECTOR
Kulkarni Samarth
Purchase · 40.0K shares
2026-06-26
★
DIRECTOR
Menzel Garry E
Purchase · 40.0K shares
2026-06-26
★
DIRECTOR
Dhingra Kapil
Purchase · 40.0K shares
2026-06-26

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
OUTPERFORM 1
OVERWEIGHT 1
NEUTRAL 1
4 GRADES IN THE LAST 12 MONTHS
BTIG BUY Wedbush OUTPERFORM Piper Sandler OVERWEIGHT Guggenheim NEUTRAL

SECTORS PEERS

PEERPRICE
AVTX$19.59COMPARE
FENC$12.27COMPARE
ENTA$13.60COMPARE
FHTX$6.00COMPARE
ABEO$5.92COMPARE
IVA$4.71COMPARE
IMRX$4.99COMPARE
CRBU$1.62COMPARE